vimarsana.com

Latest Breaking News On - Research in alzheimer disease - Page 1 : vimarsana.com

New University of Missouri program aims to grow scientific workforce

More people are living longer. By 2050, 22% of the population in the United States will be over the age of 65. Unfortunately, living longer doesn’t necessarily equate with healthy aging. Older individuals often struggle with major diseases, such as Alzheimer’s disease, cancer and strokes. While academic researchers and biomedical companies have made great strides to improve the quality of life for the elderly, there remains a gap between academia and industry a disconnect that continues to slow the process of getting scientific discoveries from the researchers to the patients who need them.

Prepared to serve

Prepared to serve
miragenews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from miragenews.com Daily Mail and Mail on Sunday newspapers.

Global Alzheimer Disease Markets to 2030: Drug Discovery, markets, Regulatory Aspects, Competitive Landscape, Clinical Features, Epidemiology and Pathology

Global Alzheimer Disease Markets to 2030: Drug Discovery, markets, Regulatory Aspects, Competitive Landscape, Clinical Features, Epidemiology and Pathology

Global Alzheimer Disease Drugs, Companies, Market Report 2020 with Profiles of 117 Companies & 89 Collaborations

Share this article Share this article ResearchAndMarkets.com s offering. Profiles of 117 companies involved in developing diagnostics and therapeutics for Alzheimer s disease are presented along with 89 collaborations. The bibliography contains over 900 publications that are cited in the report.The report is supplemented with 48 tables and 27 figures. Alzheimer s disease remains a challenge in management. With nearly 8 million sufferers from this condition in the seven major markets of the world and anticipated increases in the future. Considerable research is in progress to understand the pathomechanism of the disease and find a cure. The only drugs approved currently are acetylcholinesterase inhibitors but they do not correct the basic pathology of the disease, beta amyloid deposits and neurofibrillary tangles. Several new approaches emphasize neuroprotection as well.

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.